These results reflect continued execution in our core business coupled with strong progress from our AI-led new product portfolio. In fact, our pure AI ARR is growing at a strong double-digit rate ...

CRISPR Therapeutics is likely to witness an earnings beat as Casgevy sales climb and new CAR-T and in-vivo programs advance.

Good afternoon, everyone, and welcome to the Superior Group of Companies' Third Quarter 2025 Conference Call. With us today are Michael Benstock, Chief Executive Officer; and Mike Koempel, President ...

Quaker Chemical (($KWR)) has held its Q3 earnings call. Read on for the main highlights of the call. Quaker Chemical Reports Strong Financial ...

The earnings call transcript for Magnachip Semiconductor Corporation ( MX +0.32%) did not include any operational, financial, ...

Q3 2025 Earnings Call November 3, 2025 11:00 AM ESTCompany ParticipantsJamie Buckland - Vice President of Investor ...

DEXX Laboratories extended its streak of earnings beats this morning, reporting Q3 results that topped both EPS and revenue expectations.

Third-quarter earnings results are bolstering investor confidence that this bull market has more room to run. Here’s what investors are saying about the quarter: David Lefkowitz, head of U.S. equities ...

Wedbush raises price target to $230 ahead of Q3 earnings, projects trillion-dollar market cap on AI platform demand and ...

The collision shop operations software-as-a-service seller keeps signing deals as it expects $1B+ in revenue this year.

Fourth-Quarter Outlook -- Anticipated reported sales growth of 0.5% in Q4 2025 and organic sales growth of 1.5% in Q4 2025; ...

Earnings season kicked into high gear last week when five of the Magnificent Seven members with a combined market value of over $15 trillion reported results.